Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Case Report

Published on 02 Aug 2023

Chemotherapy-induced toxic epidermal necrolysis in a patient with multiple myeloma, a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Rui X
Meidan W
Gongqiang W
Longyi Z
Xiaoxia W
Wei C
Chenhui W

Frontiers in Oncology

doi 10.3389/fonc.2023.1227448

3,946 views
5 citations

Review

Published on 31 Jul 2023

Targeting MCL-1 protein to treat cancer: opportunities and challenges

in Pharmacology of Anti-Cancer Drugs

Shady I. Tantawy
Natalia Timofeeva
Aloke Sarkar
Varsha Gandhi

Frontiers in Oncology

doi 10.3389/fonc.2023.1226289

15,463 views
45 citations

Original Research

Published on 26 Jul 2023

Preclinical PK investigation of a novel IDO1/TDO dual inhibitor—SHR9146 in mouse plasma and tissues by LC-MS/MS

in Pharmacology of Anti-Cancer Drugs

Mei Xiao
Kan Zhong
Li Guo
Wei Li
Xiaoli Wang
Zhenjun Qiu
Taijun Hang

Frontiers in Oncology

doi 10.3389/fonc.2023.1191778

2,438 views
3 citations

Opinion

Published on 24 Jul 2023

Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia

in Pharmacology of Anti-Cancer Drugs

Chi-Hao Hu
Sheng-Nan Wu
Edmund Cheung So

Frontiers in Oncology

doi 10.3389/fonc.2023.1218821

2,494 views
4 citations

Original Research

Published on 21 Jul 2023

Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

in Pharmacology of Anti-Cancer Drugs

Daling Dong
Shixin Zhang
Bin Jiang
Wei Wei
Chao Wang
Qian Yang
Tingzhi Yan
Min Chen
Liken Zheng
Weikang Shao

Frontiers in Oncology

doi 10.3389/fonc.2023.1222716

4,445 views
3 citations

Systematic Review

Published on 20 Jul 2023

Efficacy and safety of metformin in combination with chemotherapy in cancer patients without diabetes: systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Kang Yang
Hao-hao Lu
Wei Zhao
Qingchun Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1176885

3,171 views
9 citations

Editorial

Published on 20 Jul 2023

Editorial: Anti-cancer drug delivery: lipid-based nanoparticles

in Pharmacology of Anti-Cancer Drugs

Alaaldin M. Alkilany
Abdelbary Elhissi
Walhan Alshaer
Amit Kunwar
Jyotsnendu Giri

Frontiers in Oncology

doi 10.3389/fonc.2023.1248272

2,746 views
1 citation

Original Research

Published on 18 Jul 2023

Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures

in Pharmacology of Anti-Cancer Drugs

Tomasz Kloskowski
Zuzanna Fekner
Kamil Szeliski
Michelle Paradowska
Daria Balcerczyk
Marta Rasmus
Paweł Dąbrowski
Łukasz Kaźmierski
Tomasz Drewa
Marta Pokrywczyńska

Frontiers in Oncology

doi 10.3389/fonc.2023.1222411

3,655 views
7 citations

Review

Published on 14 Jul 2023

A literature review on the impact of disasters on healthcare systems, the role of nursing in disaster management, and strategies for cancer care delivery in disaster-affected populations

in Pharmacology of Anti-Cancer Drugs

Wen Wang
Hui Li
Miao Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1178092

9,977 views
9 citations

Original Research

Published on 11 Jul 2023

PIWIL1 interacting RNA piR-017724 inhibits proliferation, invasion, and migration, and inhibits the development of HCC by silencing PLIN3

in Pharmacology of Anti-Cancer Drugs

Yi-Jing Wu
Jie Wang
Peng Zhang
Liu-Xia Yuan
Lin-Ling Ju
Hui-Xuan Wang
Lin Chen
Ya-Li Cao
Wei-Hua Cai
Yi Ni

Frontiers in Oncology

doi 10.3389/fonc.2023.1203821

2,871 views
14 citations

Review

Published on 10 Jul 2023

Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens

in Pharmacology of Anti-Cancer Drugs

Nityanand Srivastava
Salman Sadullah Usmani
Rajasekaran Subbarayan
Rashmi Saini
Pranav Kumar Pandey

Frontiers in Oncology

doi 10.3389/fonc.2023.1199105

12,331 views
35 citations

Review

Published on 06 Jul 2023

Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects

in Pharmacology of Anti-Cancer Drugs

Manasa Manjunath Hegde
Puja Sandbhor
Aishwarya J.
Vikram Gota
Jayant S. Goda

Frontiers in Oncology

doi 10.3389/fonc.2023.1168454

4,860 views
6 citations

Review

Published on 04 Jul 2023

Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies

in Pharmacology of Anti-Cancer Drugs

Ram Kumar Sahu
Sakina Ruhi
Ashok Kumar Jeppu
Husni Ahmed Al-Goshae
Ayesha Syed
Sanjay Nagdev
Retno Widyowati
Wiwied Ekasari
Jiyauddin Khan
Bedanta Bhattacharjee

Frontiers in Oncology

doi 10.3389/fonc.2023.1204722

13,360 views
24 citations

Case Report

Published on 03 Jul 2023

Intravenous immunoglobulin is safe and effective in controlling pre-existing paraneoplastic neuromuscular diseases in cancer patients treated with immune checkpoint inhibitors: two case reports and literature review

in Pharmacology of Anti-Cancer Drugs

Ge Xiong
Richard Benjamin Young
Helen Chow
Emanual Maverakis
Ricardo A. Maselli
David Paul Richman
Tianhong Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1199195

5,338 views
4 citations

Case Report

Published on 30 Jun 2023

Case Report: Advanced pulmonary sarcomatoid carcinoma with adrenal gland metastasis after sintilimab combined with anlotinib treatment

in Pharmacology of Anti-Cancer Drugs

Gangyi Dai
Lang He
Qin Yan
Yamao Li
Yuandong Huang
Bin Li
Guoping Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1167516

3,269 views
8 citations

Editorial

Published on 26 Jun 2023

Editorial: Novel targeted drugs for indolent lymphoid malignancies

in Pharmacology of Anti-Cancer Drugs

Tadeusz Robak
Bartosz Puła
Iwona Hus

Frontiers in Oncology

doi 10.3389/fonc.2023.1224528

2,067 views